Molecular Imaging Grants

Clinical Research Awards for Neurofibromatosis: Request for Letters of Intent

The Children’s Tumor Foundation announces a call for Letters of Intent for Clinical Research Awards of up to $100,000. Clinical Research Awards seeks broad-thinking novel ideas to conduct pilot clinical trials of candidate therapeutics for the treatment of tumors and other manifestations of NF1, NF2 and schwannomatosis; OR innovative studies ancillary or adjunct to clinical trials that - if successful - will contribute to the advancement of effective clinical therapies for neurofibromatosis.

Examples of projects encouraged may include but are not limited to:
- Biomarker studies adjunct to an ongoing clinical trial (may be e.g. molecular, imaging or genetic biomarkers, or other novel outcome parameters) that may better inform on and ultimately help accelerate a clinical trial.
- Preclinical/clinical collaborative studies (‘clinical co-trials’). Note however that all studies must include a clinical element – preclinical-only studies are not eligible.
- Applications to fund pilot neurofibromatosis clinical trials are welcomed an encouraged.

It is anticipated that CTF will fund up to four Clinical Research Awards of up to $100,000 (including overheads/indirect costs).

Application Process and Timeline
LOI’s due: September 15, 2010
Applicants notified: October 4, 2010

Successful LOIs will be invited to submit a full application.

Full applications due: November 15, 2010
Applicants notified: Mid-December 2010
Funding commences as early as: January 2011

Before submitting your LOI, you are strongly encouraged to contact me to discuss your idea.

Kim Hunter-Schaedle, Ph.D.
Chief Scientific Officer
Children's Tumor Foundation
Khunter-schaedle@ctf.org
Tel: 212-344-6633 x231

Conference Student Scholarships: Evolving Approaches to Early Stage Drug Discovery

Scholarship Deadline: December 2, 2010 (Midnight US Mountain Standard Time)

This meeting will cover multiple aspects of the challenges and opportunities facing drug discovery scientists. These challenges include: 1) diverse approaches to early stage discovery in a resource constrained environment, 2) evolution of preclinical drug discovery in academia, 3) evolution of drug leads/target validation from the NIH (MLPCN), 4) funding early stage/risky programs, 5) external licensing of programs and 6) advances in biomarkers/imaging to enable target selection and rapid go/no go decisions. The meeting goals are to bring together experts in all of these areas, present findings/opinions and initiate dialog on these topics. This would be the first meeting to bring together drug discovery scientists form big Pharma, biotech, academia, the MLPCN and Foundations – each with unique missions and approaches and share their respective experiences.

Keystone Symposia is offering scholarships to students and post-docs this conference season. These scholarships, of up to $1000 each, are to be used to help defray the expenses associated with conference attendance, including air (on a U.S. air carrier), ground transportation and lodging costs. Receipts will be required to receive reimbursement.

Abstracts submitted for poster presentation will be used as the basis for awarding the scholarships. Conference organizers will select the scholarship recipients based on the quality of science of the abstract and the relevance of the abstract to the conference topic. Only one application per abstract is accepted.

Keystone Symposia
221 Summit Place #272
PO Box 1630
Silverthorne, CO 80498
www.keystonesymposia.org

Financial Assistance / Student Scholarships
Phone: +1 (800) 253-0685 or
Ksenia Shambarger - +1 (970) 262-1230 extension 140
Fax: +1 (970) 262-0311

Grant for Advanced Training Elective in Molecular Diagnostics

Deadline: October 1

Award Amount: To support travel and living expenses for the training period up to $2,000. It is expected that the recipients’ own institution will continue to provide for salary and benefits during the award period.

Purpose: To provide adequate time for residents to acquaint themselves with the technology in molecular pathology and FISH. This grant is available within the United States and Canada only. Applications will not be funded for training electives which are completed or begun before notification of the award.

Time Commitment: Four (4) weeks.

Eligibility: Pathology residents and those in fellowships. Applicants must be a CAP Junior Member or have an application pending.

Selection Process:
* Need: technology is not available as needed at the applicant’s institution
* Scientific merit of the application: future use of technology
* Value to the applicant
* Letter of Recommendation

Participating Host Institutions and Programs
For a list of past participating host institutions, contact the Foundation at 800-323-4040, ext. 7324 or email your request to capfdn@cap.org.

Application Guidelines. Applicants are required to submit the following information:

1. Completed Application Form
2. Curriculum Vitae
3. Name of the training program, and the name and location of the laboratory where you would like to pursue training.
4. Narrative Summary — no more than 500 Word Formats
5. Supporting letter from the home institution’s residency program training director or department chair
6. Supporting letter from the director of the laboratory at the host institute where the training will take place

All documents must be typed.

Mail applications to:
ATG - Molecular Diagnostics
College of American Pathologists Foundation
325 Waukegan Road
Northfield, Illinois 60093-2750

OR

By Email: capfdn@cap.org
By Fax: 847.832.8324
Questions? 800.323.4040 x7324